Acquest Healthcare Stem Cell Research & Development Co., Ltd.

Acquest utilizes research and development to deliver stem cell therapies in a complete solution package to client hospitals across the world for the direct scientific and medical benefit of the patient. Acquest Stem Cell Research’s main functions are as follows: (a) to perform focused and specific research and development in the adult stem cell arena, (b) to provide a total solution packages that rapidly enable clinics and hospitals, with limited or no experience in stem cell therapy, to become cutting edge competitors in the marketplace, and (c) the presentation of stem cells in the general marketplace taking advantage of the growing interest for this technology for degenerative diseases. Incorporated in Hong Kong on January 6, 2015 as the following: ACQUEST STEM CELL RESEARCH COMPANY LIMITED 濟世幹細胞研究有限公司 & ACQUEST RESEARCH LIMITED 德華研究有限公司 A big thank you to our Phase I Core team members: Dr. Roland Neff (Founder at Acquest in HK, head Car-T cell researcher and scientist) and Dr. Roland's research team Michelle Wu (Stem Cell Researcher and Biotechnology) Dennis Chan (Asia Business Development) Pak Liu (General Manager and Company Director in Hong Kong) Daniel Coburg (APAC and EMEA Business Developer) Eileen Chen (Digital Marketing & Communications Director) Anthony Meneghella (Laboratory General Manager) Special thank you to advisors and collaborators: Professor Dragan Primorac, M.D., Ph.D. at St.Catherine Hospital Dr. Nivit Kalra, Cardiologist at Sukumvit Hospitalz Mahidol University Faculty of Medicine, Siriraj Hospital